MLB had 2 positives tests among 11,609 urine and blood samples for drugs in last year

NEW YORK CITY– Big League Baseball had simply 2 favorable tests for performance-enhancing drugs that led to discipline throughout the year ending with the World Series and exemptions for attention deficit disorder stayed at a low.

There were 11,609 tests that consisted of 9,455 urine samples and 2,154 blood samples to identify human development hormonal agent, independent program administrator Thomas M. Martin stated in his yearly report launched Friday by MLB and the gamers’ association.

That was down a little from a record 11,783 samples in 2015 that consisted of 9,550 for urine and 2,233 for blood. Overall tests were MLB’s third-highest, likewise tracking 11,619 in 2019.

Offseason urine tests in between 2023 and 2024 increased to 1,706 from 1,698, and there were 407 offseason blood tests.

The only favorable test amongst gamers on 40-man lineups included Cincinnati infielder Noelvi Marté, suspended for the very first 80 video games of 2024 following a favorable test for boldenone, and Toronto Blue Jays infielder Orelvis Martínez, suspended for 80 video games on June 23 following a favorable for clomiphene 2 days after his big league launching.

There were no favorable tests for prohibited stimulants that led to suspensions. A very first favorable including a prohibited stimulant lead to follow-up screening, and a 2nd favorable causes a 50-game suspension.

TUEs amounted to 65, of which 61 were for attention deficit disorder. The 61 matched 2023, when the overall dropped for a 10th successive year. That overall was below 72 in 2022 and 119 in 2013.

There was one TUE each for high blood pressure, sleep condition, hormonal agent function and uveitis/high eye pressure.